Rational design of balanced dual-targeting antibiotics with limited resistance

Antibiotics that inhibit multiple bacterial targets offer a promising therapeutic strategy against resistance evolution, but developing such antibiotics is challenging. Here we demonstrate that a rational design of balanced multitargeting antibiotics is feasible by using a medicinal chemistry workfl...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Nyerges Ákos
Tomasic Tihomir
Durcik Martina
Révész Tamás
Szili Petra
Draskovits Gábor
Bogár Ferenc
Skok Ziga
Zidar Nace
Daruka Lejla
Kintses Bálint
Vásárhelyi Bálint Márk
Földesi Imre
Kata Diána
Pál Csaba
Dokumentumtípus: Cikk
Megjelent: 2020
Sorozat:PLOS BIOLOGY 18 No. 10
doi:10.1371/journal.pbio.3000819

mtmt:31642956
Online Access:http://publicatio.bibl.u-szeged.hu/21017
Leíró adatok
Tartalmi kivonat:Antibiotics that inhibit multiple bacterial targets offer a promising therapeutic strategy against resistance evolution, but developing such antibiotics is challenging. Here we demonstrate that a rational design of balanced multitargeting antibiotics is feasible by using a medicinal chemistry workflow. The resultant lead compounds, ULD1 and ULD2, belonging to a novel chemical class, almost equipotently inhibit bacterial DNA gyrase and topoisomerase IV complexes and interact with multiple evolutionary conserved amino acids in the ATP-binding pockets of their target proteins. ULD1 and ULD2 are excellently potent against a broad range of gram-positive bacteria. Notably, the efficacy of these compounds was tested against a broad panel of multidrug-resistantStaphylococcus aureusclinical strains. Antibiotics with clinical relevance against staphylococcal infections fail to inhibit a significant fraction of these isolates, whereas both ULD1 and ULD2 inhibit all of them (minimum inhibitory concentration [MIC] <= 1 mu g/mL). Resistance mutations against these compounds are rare, have limited impact on compound susceptibility, and substantially reduce bacterial growth. Based on their efficacy and lack of toxicity demonstrated in murine infection models, these compounds could translate into new therapies against multidrug-resistant bacterial infections.
Terjedelem/Fizikai jellemzők:Terjedelem:31-Azonosító:e3000819
ISSN:1544-9173